Cargando…
A review of antibiotic prophylaxis for traveler’s diarrhea: past to present
As there is rapid increase in international travel to tropical and subtropical countries, there will likely be more people exposed to diarrheal pathogens in these moderate to high risk areas and subsequent increased concern for traveler’s diarrhea. The disease may appear as a mild clinical syndrome,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223076/ https://www.ncbi.nlm.nih.gov/pubmed/30455974 http://dx.doi.org/10.1186/s40794-018-0074-4 |
_version_ | 1783369353750642688 |
---|---|
author | Diptyanusa, Ajib Ngamprasertchai, Thundon Piyaphanee, Watcharapong |
author_facet | Diptyanusa, Ajib Ngamprasertchai, Thundon Piyaphanee, Watcharapong |
author_sort | Diptyanusa, Ajib |
collection | PubMed |
description | As there is rapid increase in international travel to tropical and subtropical countries, there will likely be more people exposed to diarrheal pathogens in these moderate to high risk areas and subsequent increased concern for traveler’s diarrhea. The disease may appear as a mild clinical syndrome, yet a more debilitating presentation can lead to itinerary changes and hospitalization. As bacterial etiologies are the most common causative agents of TD, the use of antibiotic prophylaxis to prevent TD has been reported among travelers for several years. The most common type of antibiotic used for TD has changed over 50 years, depending on many influencing factors. The use of antibiotic prophylaxis for TD prevention in travelers is still controversial, mainly because of difficulties balancing the risks and benefits. Many factors, such as emerging drug resistance, side effects, cost and risk behavior need to be considered. This article aims to review antibiotic prophylaxis from the 1950s to 2000s, to describe the trend and reasons for different antibiotic use in each decade. We conclude that prophylactic antibiotics should be restricted to some high-risk travelers or short-term critical trips. |
format | Online Article Text |
id | pubmed-6223076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62230762018-11-19 A review of antibiotic prophylaxis for traveler’s diarrhea: past to present Diptyanusa, Ajib Ngamprasertchai, Thundon Piyaphanee, Watcharapong Trop Dis Travel Med Vaccines Review As there is rapid increase in international travel to tropical and subtropical countries, there will likely be more people exposed to diarrheal pathogens in these moderate to high risk areas and subsequent increased concern for traveler’s diarrhea. The disease may appear as a mild clinical syndrome, yet a more debilitating presentation can lead to itinerary changes and hospitalization. As bacterial etiologies are the most common causative agents of TD, the use of antibiotic prophylaxis to prevent TD has been reported among travelers for several years. The most common type of antibiotic used for TD has changed over 50 years, depending on many influencing factors. The use of antibiotic prophylaxis for TD prevention in travelers is still controversial, mainly because of difficulties balancing the risks and benefits. Many factors, such as emerging drug resistance, side effects, cost and risk behavior need to be considered. This article aims to review antibiotic prophylaxis from the 1950s to 2000s, to describe the trend and reasons for different antibiotic use in each decade. We conclude that prophylactic antibiotics should be restricted to some high-risk travelers or short-term critical trips. BioMed Central 2018-11-07 /pmc/articles/PMC6223076/ /pubmed/30455974 http://dx.doi.org/10.1186/s40794-018-0074-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Diptyanusa, Ajib Ngamprasertchai, Thundon Piyaphanee, Watcharapong A review of antibiotic prophylaxis for traveler’s diarrhea: past to present |
title | A review of antibiotic prophylaxis for traveler’s diarrhea: past to present |
title_full | A review of antibiotic prophylaxis for traveler’s diarrhea: past to present |
title_fullStr | A review of antibiotic prophylaxis for traveler’s diarrhea: past to present |
title_full_unstemmed | A review of antibiotic prophylaxis for traveler’s diarrhea: past to present |
title_short | A review of antibiotic prophylaxis for traveler’s diarrhea: past to present |
title_sort | review of antibiotic prophylaxis for traveler’s diarrhea: past to present |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223076/ https://www.ncbi.nlm.nih.gov/pubmed/30455974 http://dx.doi.org/10.1186/s40794-018-0074-4 |
work_keys_str_mv | AT diptyanusaajib areviewofantibioticprophylaxisfortravelersdiarrheapasttopresent AT ngamprasertchaithundon areviewofantibioticprophylaxisfortravelersdiarrheapasttopresent AT piyaphaneewatcharapong areviewofantibioticprophylaxisfortravelersdiarrheapasttopresent AT diptyanusaajib reviewofantibioticprophylaxisfortravelersdiarrheapasttopresent AT ngamprasertchaithundon reviewofantibioticprophylaxisfortravelersdiarrheapasttopresent AT piyaphaneewatcharapong reviewofantibioticprophylaxisfortravelersdiarrheapasttopresent |